AAAAAA

   
Results: 1-20 |
Results: 20
THE CLINICAL DEVELOPMENT OF PACLITAXEL AND THE PACLITAXEL CARBOPLATINCOMBINATION/
Authors: SCHWARTZ GN PENDYALA L KINDLER H MEROPOL N PEREZ R RAGHAVAN D CREAVEN P
Citation: Gn. Schwartz et al., THE CLINICAL DEVELOPMENT OF PACLITAXEL AND THE PACLITAXEL CARBOPLATINCOMBINATION/, European journal of cancer, 34(10), 1998, pp. 1543-1548
SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF SPI-77 (STEALTH(R) LIPOSOMAL CISPLATIN) GIVEN EVERY 3 WEEKS IN PATIENTS WITH ADVANCED CANCER
Authors: AMANTEA MA DEMARIO MD SCHWARTZ G VOGELZANG NJ TONDA M PENDYALA L RATAIN MJ
Citation: Ma. Amantea et al., SINGLE AND MULTIPLE-DOSE PHARMACOKINETICS OF SPI-77 (STEALTH(R) LIPOSOMAL CISPLATIN) GIVEN EVERY 3 WEEKS IN PATIENTS WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 465-465
A PHASE-I STUDY OF LIPOSOME-FORMULATED CISPLATIN (SPI-77(R)) GIVEN EVERY 3 WEEKS IN PATIENTS WITH ADVANCED CANCER
Authors: DEMARIO MD VOGELZANG NJ JANISCH L HUMPHRISS E MANI S TONDA M AMANTEA MA RATAIN MJ PENDYALA L
Citation: Md. Demario et al., A PHASE-I STUDY OF LIPOSOME-FORMULATED CISPLATIN (SPI-77(R)) GIVEN EVERY 3 WEEKS IN PATIENTS WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 466-466
INITIAL CLINICAL-TRIAL AND PHARMACOKINETICS OF THYMITAQ(TM) (AG337) BY 10-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: CREAVEN PJ PENDYALA L MEROPOL NJ CLENDENINN NJ WU EY LOEWEN GM PROEFROCK A JOHNSTON A DIXON M
Citation: Pj. Creaven et al., INITIAL CLINICAL-TRIAL AND PHARMACOKINETICS OF THYMITAQ(TM) (AG337) BY 10-DAY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 167-170
TRANSLATIONAL STUDIES OF GLUTATHIONE IN BLADDER-CANCER CELL-LINES ANDHUMAN SPECIMENS
Authors: PENDYALA L VELAGAPUDI S TOTH K ZDANOWICZ J GLAVES D SLOCUM H PEREZ R HUBEN R CREAVEN PJ RAGHAVAN D
Citation: L. Pendyala et al., TRANSLATIONAL STUDIES OF GLUTATHIONE IN BLADDER-CANCER CELL-LINES ANDHUMAN SPECIMENS, Clinical cancer research, 3(5), 1997, pp. 793-798
PHASE-I AND PHARMACOKINETIC STUDY OF ETOPOSIDE PHOSPHATE BY PROTRACTED VENOUS INFUSION IN PATIENTS WITH ADVANCED CANCER
Authors: SONI N MEROPOL NJ PENDYALA L NOEL D SCHACTER LP GUNTON KE CREAVEN PJ
Citation: N. Soni et al., PHASE-I AND PHARMACOKINETIC STUDY OF ETOPOSIDE PHOSPHATE BY PROTRACTED VENOUS INFUSION IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 15(2), 1997, pp. 766-772
EFFECT OF GLUTATHIONE DEPLETION ON THE CYTOTOXICITY OF CISPLATIN AND IPROPLATIN IN A HUMAN-MELANOMA CELL-LINE
Authors: PENDYALA L PEREZ R WEINSTEIN A ZDANOWICZ J CRAVEN PJ
Citation: L. Pendyala et al., EFFECT OF GLUTATHIONE DEPLETION ON THE CYTOTOXICITY OF CISPLATIN AND IPROPLATIN IN A HUMAN-MELANOMA CELL-LINE, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 38-44
RELATIONSHIP BETWEEN HEAT-SHOCK-PROTEIN-60 (HSP60) MESSENGER-RNA EXPRESSION AND RESISTANCE TO PLATINUM ANALOGS IN HUMAN OVARIAN AND BLADDER-CARCINOMA CELL-LINES
Authors: ABUHADID M WILKES JD ELAKAWI Z PENDYALA L PEREZ RP
Citation: M. Abuhadid et al., RELATIONSHIP BETWEEN HEAT-SHOCK-PROTEIN-60 (HSP60) MESSENGER-RNA EXPRESSION AND RESISTANCE TO PLATINUM ANALOGS IN HUMAN OVARIAN AND BLADDER-CARCINOMA CELL-LINES, Cancer letters, 119(1), 1997, pp. 63-70
UNUSUAL CENTRAL-NERVOUS-SYSTEM TOXICITY IN A PHASE-I STUDY OF N(1)N(11)DIETHYLNORSPERMINE IN PATIENTS WITH ADVANCED MALIGNANCY
Authors: CREAVEN PJ PEREZ R PENDYALA L MEROPOL NJ LOEWEN G LEVINE E BERGHORN E RAGHAVAN D
Citation: Pj. Creaven et al., UNUSUAL CENTRAL-NERVOUS-SYSTEM TOXICITY IN A PHASE-I STUDY OF N(1)N(11)DIETHYLNORSPERMINE IN PATIENTS WITH ADVANCED MALIGNANCY, Investigational new drugs, 15(3), 1997, pp. 227-234
PACLITAXEL AND CARBOPLATIN IN EARLY PHASE STUDIES - ROSWELL-PARK-CANCER-INSTITUTE EXPERIENCE IN THE SUBSET OF PATIENTS WITH LUNG-CANCER
Authors: CREAVEN PJ RAGHAVAN D PENDYALA L LOEWEN G KINDLER HL BERGHORN EJ
Citation: Pj. Creaven et al., PACLITAXEL AND CARBOPLATIN IN EARLY PHASE STUDIES - ROSWELL-PARK-CANCER-INSTITUTE EXPERIENCE IN THE SUBSET OF PATIENTS WITH LUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 138-143
INDUCTION OF GAMMA-GLUTAMYL-TRANSPEPTIDASE MESSENGER-RNA BY PLATINUM COMPLEXES IN A HUMAN OVARIAN-CARCINOMA CELL-LINE
Authors: ELAKAWI Z ZDANOWICZ J CREAVEN PJ ABUHADID M PEREZ R PENDYALA L
Citation: Z. Elakawi et al., INDUCTION OF GAMMA-GLUTAMYL-TRANSPEPTIDASE MESSENGER-RNA BY PLATINUM COMPLEXES IN A HUMAN OVARIAN-CARCINOMA CELL-LINE, Oncology research, 8(10-11), 1996, pp. 415-423
ALTERED GLUTATHIONE METABOLISM IN OXALIPLATIN RESISTANT OVARIAN-CARCINOMA CELLS
Authors: ELAKAWI Z ABUHADID M PEREZ R GLAVY J ZDANOWICZ J CREAVEN PJ PENDYALA L
Citation: Z. Elakawi et al., ALTERED GLUTATHIONE METABOLISM IN OXALIPLATIN RESISTANT OVARIAN-CARCINOMA CELLS, Cancer letters, 105(1), 1996, pp. 5-14
EARLY PHASE STUDIES WITH PACLITAXEL LOW-DOSE CARBOPLATIN IN PATIENTS WITH SOLID TUMORS/
Authors: CREAVEN PJ RAGHAVAN D PEREZ RP PENDYALA L BERGHORN EJ LOEWEN G MEROPOL NJ
Citation: Pj. Creaven et al., EARLY PHASE STUDIES WITH PACLITAXEL LOW-DOSE CARBOPLATIN IN PATIENTS WITH SOLID TUMORS/, Seminars in oncology, 23(6), 1996, pp. 26-31
PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF N-ACETYLCYSTEINE, A POTENTIAL CHEMOPREVENTIVE AGENT DURING A PHASE-I TRIAL
Authors: PENDYALA L CREAVEN PJ
Citation: L. Pendyala et Pj. Creaven, PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF N-ACETYLCYSTEINE, A POTENTIAL CHEMOPREVENTIVE AGENT DURING A PHASE-I TRIAL, Cancer epidemiology, biomarkers & prevention, 4(3), 1995, pp. 245-251
INTRACELLULAR GLUTATHIONE AND CYTOTOXICITY OF PLATINUM COMPLEXES
Authors: PENDYALA L CREAVEN PJ PEREZ R ZDANOWICZ JR RAGHAVAN D
Citation: L. Pendyala et al., INTRACELLULAR GLUTATHIONE AND CYTOTOXICITY OF PLATINUM COMPLEXES, Cancer chemotherapy and pharmacology, 36(4), 1995, pp. 271-278
CYTOTOXICITY, CELLULAR ACCUMULATION AND DNA-BINDING OF OXALIPLATIN ISOMERS
Authors: PENDYALA L KIDANI Y PEREZ R WILKES J BERNACKI RJ CREAVEN PJ
Citation: L. Pendyala et al., CYTOTOXICITY, CELLULAR ACCUMULATION AND DNA-BINDING OF OXALIPLATIN ISOMERS, Cancer letters, 97(2), 1995, pp. 177-184
PHASE-I STUDY OF PACLITAXEL AND CARBOPLATIN - IMPLICATIONS FOR TRIALSIN HEAD AND NECK-CANCER
Authors: CREAVEN P RAGHAVAN D PENDYALA L PEREZ R LOEWEN G MEROPOL N LEVINE E HICKS W
Citation: P. Creaven et al., PHASE-I STUDY OF PACLITAXEL AND CARBOPLATIN - IMPLICATIONS FOR TRIALSIN HEAD AND NECK-CANCER, Seminars in oncology, 22(5), 1995, pp. 13-16
URINARY AND ERYTHROCYTE POLYAMINES DURING THE EVALUATION OF ORAL ALPHA-DIFLUOROMETHYLORNITHINE IN A PHASE-I CHEMOPREVENTION CLINICAL-TRIAL
Authors: PENDYALA L CREAVEN PJ PORTER CW
Citation: L. Pendyala et al., URINARY AND ERYTHROCYTE POLYAMINES DURING THE EVALUATION OF ORAL ALPHA-DIFLUOROMETHYLORNITHINE IN A PHASE-I CHEMOPREVENTION CLINICAL-TRIAL, Cancer epidemiology, biomarkers & prevention, 2(3), 1993, pp. 235-241
EVALUATION OF ALPHA-DIFLUOROMETHYLORNITHINE AS A POTENTIAL CHEMOPREVENTIVE AGENT - TOLERANCE TO DAILY ORAL-ADMINISTRATION IN HUMANS
Authors: CREAVEN PJ PENDYALA L PETRELLI NJ
Citation: Pj. Creaven et al., EVALUATION OF ALPHA-DIFLUOROMETHYLORNITHINE AS A POTENTIAL CHEMOPREVENTIVE AGENT - TOLERANCE TO DAILY ORAL-ADMINISTRATION IN HUMANS, Cancer epidemiology, biomarkers & prevention, 2(3), 1993, pp. 243-247
IN-VITRO CYTOTOXICITY, PROTEIN-BINDING, RED-BLOOD-CELL PARTITIONING, AND BIOTRANSFORMATION OF OXALIPLATIN
Authors: PENDYALA L CREAVEN PJ
Citation: L. Pendyala et Pj. Creaven, IN-VITRO CYTOTOXICITY, PROTEIN-BINDING, RED-BLOOD-CELL PARTITIONING, AND BIOTRANSFORMATION OF OXALIPLATIN, Cancer research, 53(24), 1993, pp. 5970-5976
Risultati: 1-20 |